Philip Roveto

Person

San Francisco, CA, US

People

Patents Grantslast 30 patents

Information Patent Grant
CIS-morpholinone and other compounds as MDM2 inhibitors for the tre...
- Patent number 11,407,721
- Issue date Aug 9, 2022
- Amgen Inc.
- Michael D. Bartberger
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Piperidinone derivatives as MDM2 inhibitors for the treatment of ca...
- Patent number 9,593,129
- Issue date Mar 14, 2017
- Amgen, Inc.
- Michael D. Bartberger
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Heterocyclic compounds as MDM2 inhibitors for the treatment of cancer
- Patent number 9,376,425
- Issue date Jun 28, 2016
- Amgen, Inc.
- Michael D. Bartberger
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Piperidinone derivatives as MDM2 inhibitors for the treatment of ca...
- Patent number 9,296,736
- Issue date Mar 29, 2016
- Amgen Inc.
- Michael D. Bartberger
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Method of treating cancer with substituted amide derivatives
- Patent number 8,685,983
- Issue date Apr 1, 2014
- Amgen Inc.
- Tae-Seong Kim
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted amide derivatives and methods of use
- Patent number 8,088,794
- Issue date Jan 3, 2012
- Amgen Inc.
- Tae-Seong Kim
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Ca...
- Publication number 20240300892
- Publication date Sep 12, 2024
- Amgen Inc.
- Michael D. Bartberger
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Ca...
- Publication number 20220169611
- Publication date Jun 2, 2022
- Amgen Inc.
- Michael D. Bartberger
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Ca...
- Publication number 20210179560
- Publication date Jun 17, 2021
- Amgen Inc.
- Michael D. Bartberger
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Ca...
- Publication number 20190062276
- Publication date Feb 28, 2019
- Amgen Inc.
- Michael D. Bartberger
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CIS-MORPHOLINONE AND OTHER COMPOUNDS AS MDM2 INHIBITORS FOR THE TRE...
- Publication number 20180354918
- Publication date Dec 13, 2018
- Amgen Inc.
- Michael D. BARTBERGER
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Ca...
- Publication number 20170144971
- Publication date May 25, 2017
- Amgen Inc.
- Michael D. BARTBERGER
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Ca...
- Publication number 20160137667
- Publication date May 19, 2016
- Amgen Inc.
- Michael D. BARTBERGER
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CIS-MORPHOLINONE AND OTHER COMPOUNDS AS MDM2 INHIBITORS FOR THE TRE...
- Publication number 20160002185
- Publication date Jan 7, 2016
- Amgen Inc.
- Michael D. BARTBERGER
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PIPERIDINONE DERIVATIVES AS MDM2 INHIBITORS FOR THE TREATMENT OF CA...
- Publication number 20140315895
- Publication date Oct 23, 2014
- Michael D. Bartberger
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HETEROCYCLIC COMPOUNDS AS MDM2 INHIBITORS FOR THE TREATMENT OF CANCER
- Publication number 20140235629
- Publication date Aug 21, 2014
- Michael D. Bartberger
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PIPERIDINONE DERIVATIVES AS MDM2 INHIBITORS FOR THE TREATMENT OF CA...
- Publication number 20140011796
- Publication date Jan 9, 2014
- Amgen Inc.
- Michael David BARTBERGER
- C07 - ORGANIC CHEMISTRY
Information Patent Application
METHOD OF TREATING CANCER WITH SUBSTITUTED AMIDE DERIVATIVES
- Publication number 20120070413
- Publication date Mar 22, 2012
- Tae-Seong KIM
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PIPERIDINONE DERIVATIVES AS MDM2 INHIBITORS FOR THE TREATMENT OF CA...
- Publication number 20110319378
- Publication date Dec 29, 2011
- Amgen Inc.
- Michael David BARTBERGER
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SUBSTITUTED AMIDE DERIVATIVES AND METHODS OF USE
- Publication number 20110118252
- Publication date May 19, 2011
- Amgen Inc.
- Tae-Seong Kim
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Substituted amide derivatives and methods of use
- Publication number 20080312232
- Publication date Dec 18, 2008
- Amgen Inc.
- Tae-Seong Kim
- C07 - ORGANIC CHEMISTRY

Philip Roveto

Person

Patents Grantslast 30 patents

CIS-morpholinone and other compounds as MDM2 inhibitors for the tre...

Piperidinone derivatives as MDM2 inhibitors for the treatment of ca...

Heterocyclic compounds as MDM2 inhibitors for the treatment of cancer

Piperidinone derivatives as MDM2 inhibitors for the treatment of ca...

Method of treating cancer with substituted amide derivatives

Substituted amide derivatives and methods of use

Patents Applicationslast 30 patents

Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Ca...

Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Ca...

Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Ca...

Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Ca...

CIS-MORPHOLINONE AND OTHER COMPOUNDS AS MDM2 INHIBITORS FOR THE TRE...

Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Ca...

Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Ca...

CIS-MORPHOLINONE AND OTHER COMPOUNDS AS MDM2 INHIBITORS FOR THE TRE...

PIPERIDINONE DERIVATIVES AS MDM2 INHIBITORS FOR THE TREATMENT OF CA...

HETEROCYCLIC COMPOUNDS AS MDM2 INHIBITORS FOR THE TREATMENT OF CANCER

PIPERIDINONE DERIVATIVES AS MDM2 INHIBITORS FOR THE TREATMENT OF CA...

METHOD OF TREATING CANCER WITH SUBSTITUTED AMIDE DERIVATIVES

PIPERIDINONE DERIVATIVES AS MDM2 INHIBITORS FOR THE TREATMENT OF CA...

SUBSTITUTED AMIDE DERIVATIVES AND METHODS OF USE

Substituted amide derivatives and methods of use